{"id":414779,"date":"2020-07-09T12:42:46","date_gmt":"2020-07-09T10:42:46","guid":{"rendered":"https:\/\/businesstech.co.za\/news\/?p=414779"},"modified":"2020-07-09T12:42:46","modified_gmt":"2020-07-09T10:42:46","slug":"covid-19-fighting-drug-to-be-available-in-south-africa","status":"publish","type":"post","link":"https:\/\/businesstech.co.za\/news\/business\/414779\/covid-19-fighting-drug-to-be-available-in-south-africa\/","title":{"rendered":"Covid-19-fighting drug to be available in South Africa"},"content":{"rendered":"<p>Remdesivir, a drug that has been shown reduce the time to recovery of Covid-19 patients is expected to be available in South Africa soon.<\/p>\n<p>Cipla, through an agreement with Gilead Sciences Inc, was granted a license to manufacture and distribute the antiviral medicine in 127 countries, including South Africa.<\/p>\n<p>Citing Cipla South Africa chief executive officer, Paul Miller, <a href=\"https:\/\/www.businesslive.co.za\/bd\/national\/health\/2020-07-02-cipla-to-bring-covid-19-treatment-remdesivir-to-sa\/\" target=\"_blank\" rel=\"noopener noreferrer\">BusinessDay<\/a> reported that the company has earmarked an initial batch of 35,000 vials for the country, which is anticipated to arrive in the week of 20 July.<\/p>\n<p>Remdesivir has not yet been registered by the SA Health Products Regulatory Authority (Sahpra), which means it needs to be imported using a section 21 exemption to the Medicines and Related Substances Act, Miller said.<\/p>\n<p>Section 21 exemptions are used for medicines that have not been thoroughly investigated by Sahpra, but have been approved by regulators in other countries.<\/p>\n<p><strong>Clinical trial<\/strong><\/p>\n<p>Remdesivir came to prominence in the US <a href=\"https:\/\/www.niaid.nih.gov\/news-events\/nih-clinical-trial-shows-remdesivir-accelerates-recovery-advanced-covid-19\" target=\"_blank\" rel=\"noopener noreferrer\">after a clinical trial<\/a> showed that it accelerates recovery from advanced Covid-19.<\/p>\n<p>Preliminary results indicated that patients who received the drug had a 31% faster time to recovery than those who received placebo.<\/p>\n<p>Specifically, the median time to recovery was 11 days for patients treated with Remdesivir compared with 15 days for those who received placebo.<\/p>\n<p>Results also suggested a survival benefit, with a mortality rate of 8.0% for the group receiving Remdesivir versus 11.6% for the placebo group.<\/p>\n<p>In an <a href=\"http:\/\/www.702.co.za\/articles\/389025\/cipla-plans-to-bring-covid-19-treatment-remdesivir-to-sa-at-an-affordable-price?fbclid=IwAR0EFlKasCFnVt5eG9pniapE4bDDLbcwtGf46AUizh3SrN0tRTh21K6jwa4\" target=\"_blank\" rel=\"noopener noreferrer\">interview with 702<\/a>, Miller said that instead of only relieving the symptoms, the drug has been shown to fight the virus in the body. &#8220;This is what makes it so unique and exciting as a medication,&#8221; he said.<\/p>\n<p>He said that in the US, the drug costs around $390 for a vial, with between six or 10 vials needed per patient &#8211; depending on the length of stay in hospital.<\/p>\n<p>Miller said that Cipla manufactures the drug in India as an injectible, with the price coming down to $55 per vial. &#8220;We&#8217;re hoping that this is going to make the medication&#8230; affordable, and accessible.&#8221;<\/p>\n<p>He said that the company is working with the health authorities to get approval to bring the product to market, adding that the drug has a very strong clinical history.<\/p>\n<p><strong>Covid-19 surge in SA<\/strong><\/p>\n<p>Health minister Zweli Mkhize told Parliament on Wednesday that the country is likely to run out of intensive-care unit beds within four weeks.<\/p>\n<p>The scarcity of beds will come even as the number of infections, which are expected to hit a high point in August, are expected to be lower than initially projected, he said.<\/p>\n<p>\u201cThe storm that we have consistently warned South Africans about is now arriving. As a nation we have every reason to be united in this fight against Covid-19,&#8221; he said.<\/p>\n<p>The minister said that the Department of Health has developed and is implementing the Surge Strategy, in anticipation of the peak.<\/p>\n<p>\u201cThis will ensure that the department increases capacity for Covid-19, while at the same time continuing to deliver other health services to the health care users.<\/p>\n<p>&#8220;During this process, the department repurposed a total of 27,467 beds for Covid-19, which has increased to 40,309 beds as the provinces started to experience a sudden increase in the number of cases,\u201d he said.<\/p>\n<p><strong>A new epicentre<\/strong><\/p>\n<p>With over 75,000 confirmed Covid-19 cases, Gauteng has overtaken the Western Cape as the epicentre with the highest number of infections, the health minister said.<\/p>\n<p>As of Wednesday, the number of infections grew by 8,810 bringing to 224,665 the confirmed Covid-19 cases reported in South Africa.<\/p>\n<p>A further 100 people succumbed to Covid-19.<\/p>\n<p>Of the new additional fatalities, 47 were from Western Cape, 18 from the Eastern Cape, 15 from Mpumalanga, 18 from KwaZulu-Natal and two from Limpopo, taking the death toll to 3,602.<\/p>\n<p>&#8220;We convey our condolences to the loved ones of the departed and thank the health care workers who treated the deceased,&#8221; the minister said.<\/p>\n<p>Meanwhile, the number of recoveries is 106,842, which translates to a recovery rate of 47.5%.<\/p>\n<p>Gauteng, which is now the Coronavirus epicentre, has 75,015 cases, followed by the Western Cape 73,292, Eastern Cape 42,357 and KwaZulu-Natal with 17,962 cases.<\/p>\n<hr \/>\n<p><strong>Read: <a href=\"https:\/\/businesstech.co.za\/news\/business\/414723\/joburg-and-cape-town-hike-tariffs-as-consumers-buckle-under-coronavirus-pressure\/\" target=\"_blank\" rel=\"noopener noreferrer\">Joburg and Cape Town hike tariffs as consumers buckle under coronavirus pressure<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Remdesivir, a drug that has been shown reduce the time to recovery of Covid-19 patients, is expected to be available in South Africa soon.<\/p>\n","protected":false},"author":10,"featured_media":414783,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9872],"tags":[15079,26],"class_list":["post-414779","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","tag-cipla","tag-headline"],"_links":{"self":[{"href":"https:\/\/businesstech.co.za\/news\/wp-json\/wp\/v2\/posts\/414779","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/businesstech.co.za\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/businesstech.co.za\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/businesstech.co.za\/news\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/businesstech.co.za\/news\/wp-json\/wp\/v2\/comments?post=414779"}],"version-history":[{"count":4,"href":"https:\/\/businesstech.co.za\/news\/wp-json\/wp\/v2\/posts\/414779\/revisions"}],"predecessor-version":[{"id":414805,"href":"https:\/\/businesstech.co.za\/news\/wp-json\/wp\/v2\/posts\/414779\/revisions\/414805"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/businesstech.co.za\/news\/wp-json\/wp\/v2\/media\/414783"}],"wp:attachment":[{"href":"https:\/\/businesstech.co.za\/news\/wp-json\/wp\/v2\/media?parent=414779"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/businesstech.co.za\/news\/wp-json\/wp\/v2\/categories?post=414779"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/businesstech.co.za\/news\/wp-json\/wp\/v2\/tags?post=414779"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}